FdaApplication
ANDA 207181
Identifiers
- fda_app_no: ANDA207181
Properties
| Property | Value |
|---|---|
| applicant_name | REGCON HOLDINGS LLC |
| application_type | ANDA |
| approval_date | 2017-03-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ESOMEPRAZOLE SODIUM | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE;INTRAVENOUS |
1 product